BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15794826)

  • 1. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.
    Ganslandt O; Stadlbauer A; Fahlbusch R; Kamada K; Buslei R; Blumcke I; Moser E; Nimsky C
    Neurosurgery; 2005 Apr; 56(2 Suppl):291-8; discussion 291-8. PubMed ID: 15794826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.
    Croteau D; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rock JP; Mikkelsen T
    Neurosurgery; 2001 Oct; 49(4):823-9. PubMed ID: 11564242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    Preul MC; Leblanc R; Caramanos Z; Kasrai R; Narayanan S; Arnold DL
    Can J Neurol Sci; 1998 Feb; 25(1):13-22. PubMed ID: 9532276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma.
    McKnight TR; Noworolski SM; Vigneron DB; Nelson SJ
    J Magn Reson Imaging; 2001 Feb; 13(2):167-77. PubMed ID: 11169821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
    Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance chemical shift imaging (1H CSI)-directed stereotactic biopsy.
    Son BC; Kim MC; Choi BG; Kim EN; Baik HM; Choe BY; Naruse S; Kang JK
    Acta Neurochir (Wien); 2001; 143(1):45-9; discussion 49-50. PubMed ID: 11345717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.
    Dowling C; Bollen AW; Noworolski SM; McDermott MW; Barbaro NM; Day MR; Henry RG; Chang SM; Dillon WP; Nelson SJ; Vigneron DB
    AJNR Am J Neuroradiol; 2001 Apr; 22(4):604-12. PubMed ID: 11290466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
    Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence.
    McKnight TR; von dem Bussche MH; Vigneron DB; Lu Y; Berger MS; McDermott MW; Dillon WP; Graves EE; Pirzkall A; Nelson SJ
    J Neurosurg; 2002 Oct; 97(4):794-802. PubMed ID: 12405365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection.
    Bohinski RJ; Kokkino AK; Warnick RE; Gaskill-Shipley MF; Kormos DW; Lukin RR; Tew JM
    Neurosurgery; 2001 Apr; 48(4):731-42; discussion 742-4. PubMed ID: 11322433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of true frameless stereotaxy: in vivo measurement and laboratory phantom studies. Technical note.
    Dorward NL; Alberti O; Palmer JD; Kitchen ND; Thomas DG
    J Neurosurg; 1999 Jan; 90(1):160-8. PubMed ID: 10413173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
    Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ
    J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
    Liu H; Hall WA; Martin AJ; Truwit CL
    J Magn Reson Imaging; 2001 Jul; 14(1):1-7. PubMed ID: 11436207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
    Graves EE; Nelson SJ; Vigneron DB; Verhey L; McDermott M; Larson D; Chang S; Prados MD; Dillon WP
    AJNR Am J Neuroradiol; 2001 Apr; 22(4):613-24. PubMed ID: 11290467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
    García-Martín ML; Hérigault G; Rémy C; Farion R; Ballesteros P; Coles JA; Cerdán S; Ziegler A
    Cancer Res; 2001 Sep; 61(17):6524-31. PubMed ID: 11522650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.
    Heesters MA; Kamman RL; Mooyaart EL; Go KG
    J Neurooncol; 1993 Jul; 17(1):27-35. PubMed ID: 8120569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
    Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
    Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.